Nuwellis, Inc.(NUWE)Earnings, Financials & Key Ratios
NUWE•NASDAQ
$1.10
$2M mkt cap·Price updated May 7, 2026
AboutNuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.Show more
- Revenue$8M-5.4%
- EBITDA-$11M-0.1%
- Net Income-$18M-56.9%
- EPS (Diluted)-25.39-217.4%
- Gross Margin61.96%-7.1%
- EBITDA Margin-129.25%-5.8%
- Operating Margin-134.29%-6.8%
- Net Margin-211.81%-65.8%
- ROE-382.72%-67.0%
- ROIC-433.04%+43.5%
- Debt/Equity0.13+49.8%
- Interest Coverage-1.05+46.3%
NUWE Key Insights
Nuwellis, Inc. (NUWE) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Efficient asset utilization: 1.4x turnover
✗Weaknesses
- ✗Weak Piotroski F-Score: 3/9
- ✗Negative free cash flow
- ✗Weak momentum: RS Rating 5 (bottom 5%)
- ✗Shares diluted 100.0% in last year
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
NUWE Price & Volume
Nuwellis, Inc. (NUWE) stock price & volume — 10-year historical chart
Loading chart...
NUWE Growth Metrics
Nuwellis, Inc. (NUWE) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years63.93%
5 Years2.14%
3 Years-1.08%
TTM-5.38%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-56.92%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-291.62%
Return on Capital
10 Years-173.97%
5 Years-133.42%
3 Years-168.16%
Last Year-213.76%
NUWE Peer Comparison
Nuwellis, Inc. (NUWE) competitors in Renal, dialysis, and blood purification — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 NVCR | 1.92B | 16.83 | -13.80 | 8.28% | -25.66% | -50.82% | 0.85 | |
 ANGO | 468.54M | 11.27 | -13.58 | -3.76% | -9.02% | -15.71% | ||
 ATRC | 1.41B | 27.80 | -115.83 | 14.88% | -0.83% | -0.95% | 0.18 | |
 CNMD | 1.17B | 38.09 | 25.22 | 5.16% | 4% | 5.4% | 0.81 | |
 MMSI | 3.72B | 62.33 | 29.26 | 11.66% | 9.03% | 8.95% | 0.57 | |
 BDX | 55.53B | 153.26 | 26.29 | 8.23% | 5.33% | 4.54% | 0.76 | |
 BSX | 84.08B | 56.58 | 29.16 | 19.87% | 14.4% | 12.4% | 0.51 | |
 MDT | 99.94B | 77.96 | 21.60 | 3.62% | 13% | 9.45% | 0.59 |
Compare NUWE vs Peers
Nuwellis, Inc. (NUWE) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
NUWE Income Statement
Nuwellis, Inc. (NUWE) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 3.55M | 5M | 5.51M | 7.44M | 7.92M | 8.54M | 8.86M | 8.74M | 8.27M |
| Revenue Growth % | 175.64% | 40.67% | 10.26% | 35.02% | 6.45% | 7.85% | 3.76% | -1.4% | -5.38% |
| Cost of Goods Sold | 2.76M | 3.67M | 2.66M | 3.38M | 3.43M | 3.79M | 3.88M | 2.91M | 3.15M |
| COGS % of Revenue | 77.77% | 73.43% | 48.27% | 45.48% | 43.3% | 44.34% | 43.78% | 33.34% | 38.04% |
| Gross Profit | 790K▲ 0% | 1.33M▲ 68.1% | 2.85M▲ 114.7% | 4.06M▲ 42.3% | 4.49M▲ 10.7% | 4.75M▲ 5.9% | 4.98M▲ 4.8% | 5.83M▲ 16.9% | 5.12M▼ 12.0% |
| Gross Margin % | 22.23% | 26.57% | 51.73% | 54.52% | 56.7% | 55.66% | 56.22% | 66.66% | 61.96% |
| Gross Profit Growth % | 37.15% | 68.1% | 114.68% | 42.3% | 10.7% | 5.88% | 4.79% | 16.92% | -12.05% |
| Operating Expenses | 11.65M | 18.36M | 20.96M | 21.09M | 24.02M | 21.93M | 22.61M | 16.81M | 16.23M |
| OpEx % of Revenue | 327.92% | 367.43% | 380.28% | 283.36% | 303.21% | 256.65% | 255.11% | 192.38% | 196.25% |
| Selling, General & Admin | 10.17M | 15.31M | 16.29M | 17.42M | 19.04M | 17.58M | 17.19M | 0 | 13.52M |
| SG&A % of Revenue | 286.24% | 306.34% | 295.5% | 234.07% | 240.36% | 205.83% | 193.94% | - | 163.46% |
| Research & Development | 1.48M | 3.05M | 4.67M | 3.67M | 4.98M | 4.34M | 5.42M | 3.21M | 2.71M |
| R&D % of Revenue | 41.68% | 61.08% | 84.78% | 49.29% | 62.85% | 50.83% | 61.17% | 36.72% | 32.79% |
| Other Operating Expenses | 28K | 10K | 0 | -1K | 0 | 75K | 0 | 13.61M | 0 |
| Operating Income | -14.81M▲ 0% | -17.04M▼ 15.0% | -18.11M▼ 6.3% | -17.03M▲ 6.0% | -19.53M▼ 14.7% | -17.17M▲ 12.1% | -17.63M▼ 2.7% | -10.99M▲ 37.7% | -11.11M▼ 1.1% |
| Operating Margin % | -416.89% | -340.86% | -328.54% | -228.84% | -246.51% | -201% | -198.89% | -125.72% | -134.29% |
| Operating Income Growth % | 5.43% | -15.01% | -6.28% | 5.95% | -14.67% | 12.06% | -2.67% | 37.67% | -1.07% |
| EBITDA | -14.04M | -16.8M | -17.87M | -16.65M | -19.04M | -16.8M | -17.27M | -10.68M | -10.69M |
| EBITDA Margin % | -395.24% | -336.21% | -324.21% | -223.79% | -240.35% | -196.64% | -194.81% | -122.17% | -129.25% |
| EBITDA Growth % | 6.16% | -19.66% | -6.33% | 6.8% | -14.33% | 11.76% | -2.79% | 38.16% | -0.1% |
| D&A (Non-Cash Add-back) | 769K | 232K | 239K | 376K | 488K | 372K | 362K | 310K | 417K |
| EBIT | -10.86M | -17.04M | -18.11M | -17.03M | -19.55M | -5.27M | -16.72M | -10.84M | -11.11M |
| Net Interest Income | 0 | 0 | 0 | 0 | 0 | -9.25M | -3.48M | -5.61M | -10.55M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 2.54M | 0 | 0 | 0 | 0 | 9.25M | 3.48M | 5.61M | 10.55M |
| Other Income/Expense | 1.44M | 10K | 0 | 1.2M | -19K | 2.65M | -2.57M | -172K | -6.41M |
| Pretax Income | -13.38M▲ 0% | -17.03M▼ 27.3% | -18.11M▼ 6.3% | -15.83M▲ 12.6% | -19.55M▼ 23.5% | -14.52M▲ 25.7% | -20.2M▼ 39.2% | -11.16M▲ 44.8% | -17.52M▼ 57.0% |
| Pretax Margin % | -376.47% | -340.66% | -328.54% | -212.7% | -246.75% | -169.92% | -227.9% | -127.69% | -211.8% |
| Income Tax | 6K | 6K | 8K | 9K | 9K | 9K | 8K | 5K | 5K |
| Effective Tax Rate % | -0.04% | -0.04% | -0.04% | -0.06% | -0.05% | -0.06% | -0.04% | -0.04% | -0.03% |
| Net Income | -13.38M▲ 0% | -17.03M▼ 27.3% | -18.11M▼ 6.4% | -15.84M▲ 12.6% | -19.55M▼ 23.5% | -14.53M▲ 25.7% | -20.21M▼ 39.1% | -11.16M▲ 44.8% | -17.52M▼ 56.9% |
| Net Margin % | -376.64% | -340.78% | -328.69% | -212.82% | -246.86% | -170.02% | -227.99% | -127.75% | -211.81% |
| Net Income Growth % | 15.26% | -27.28% | -6.35% | 12.58% | -23.48% | 25.72% | -39.13% | 44.75% | -56.89% |
| Net Income (Continuing) | -13.38M | -17.03M | -18.11M | -15.84M | -19.55M | -14.53M | -20.21M | -11.16M | -17.52M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -999999.00▲ 0% | -999999.00▲ 0.0% | -411681.82▲ 58.8% | -20276.57▲ 95.1% | -10004.09▲ 50.7% | -2921.95▲ 70.8% | -360.07▲ 87.7% | -8.00▲ 97.8% | -25.39▼ 217.4% |
| EPS Growth % | 15.26% | 4.54% | 90.33% | 95.07% | 50.66% | 70.79% | 87.68% | 97.78% | -217.38% |
| EPS (Basic) | -999999.00 | -999999.00 | -411681.82 | -20276.57 | -10004.09 | -2921.95 | -360.07 | -8.00 | -25.39 |
| Diluted Shares Outstanding | 3 | 4 | 44 | 781 | 1.96K | 4.97K | 56.13K | 1.33M | 6.9M |
| Basic Shares Outstanding | 3 | 4 | 44 | 781 | 1.96K | 4.97K | 56.13K | 1.33M | 6.9M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
NUWE Balance Sheet
Nuwellis, Inc. (NUWE) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 17.86M | 8.13M | 4.04M | 18.54M | 28.13M | 22.77M | 8.21M | 8.86M | 5.19M |
| Cash & Short-Term Investments | 15.6M | 5.48M | 1.28M | 14.44M | 24.2M | 18.31M | 3.8M | 5.09M | 1.08M |
| Cash Only | 15.6M | 5.48M | 1.28M | 14.44M | 8.74M | 17.74M | 3.8M | 5.09M | 1.08M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 15.46M | 569K | 0 | 0 | 0 |
| Accounts Receivable | 545K | 786K | 799K | 905K | 750K | 1.41M | 1.95M | 1.73M | 1.49M |
| Days Sales Outstanding | 55.99 | 57.4 | 52.92 | 44.39 | 34.56 | 60.07 | 80.34 | 72.12 | 65.89 |
| Inventory | 1.59M | 1.66M | 1.8M | 2.96M | 2.84M | 2.66M | 2M | 1.72M | 1.91M |
| Days Inventory Outstanding | 209.78 | 164.9 | 246.58 | 318.94 | 302.54 | 256.41 | 187.81 | 215.19 | 221.6 |
| Other Current Assets | 136K | 203K | -1 | 237K | 0 | 396K | 461K | 0 | 698K |
| Total Non-Current Assets | 591K | 649K | 1.57M | 1.48M | 2.29M | 1.9M | 1.56M | 1.01M | 932K |
| Property, Plant & Equipment | 570K | 536K | 1.43M | 1.46M | 2.27M | 1.88M | 1.44M | 988K | 661K |
| Fixed Asset Turnover | 6.23x | 9.32x | 3.85x | 5.11x | 3.49x | 4.54x | 6.15x | 8.85x | 12.51x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 21K | 113K | 133K | 21K | 21K | 21K | 120K | 21K | 271K |
| Total Assets | 18.45M▲ 0% | 8.78M▼ 52.4% | 5.6M▼ 36.2% | 20.01M▲ 257.2% | 30.42M▲ 52.0% | 24.67M▼ 18.9% | 9.77M▼ 60.4% | 9.86M▲ 1.0% | 6.12M▼ 38.0% |
| Asset Turnover | 0.19x | 0.57x | 0.98x | 0.37x | 0.26x | 0.35x | 0.91x | 0.89x | 1.35x |
| Asset Growth % | 147.02% | -52.45% | -36.17% | 257.23% | 51.99% | -18.88% | -60.4% | 0.96% | -37.98% |
| Total Current Liabilities | 2.09M | 2.84M | 3.35M | 3.58M | 3.31M | 4.69M | 3.17M | 2.56M | 3.03M |
| Accounts Payable | 862K | 1.13M | 1.49M | 1.1M | 1.41M | 2.25M | 2.38M | 1.64M | 2.23M |
| Days Payables Outstanding | 113.87 | 112.68 | 204.18 | 118.32 | 150.47 | 216.32 | 223.83 | 205.42 | 258.26 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 261K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 208K | 1.71M | 85K | 66K | 36K | 58K | 576K | 41K | 545K |
| Current Ratio | 8.54x | 2.86x | 1.20x | 5.17x | 8.50x | 4.86x | 2.59x | 3.46x | 1.71x |
| Quick Ratio | 7.78x | 2.28x | 0.67x | 4.35x | 7.65x | 4.29x | 1.96x | 2.79x | 1.08x |
| Cash Conversion Cycle | 151.89 | 109.61 | 95.32 | 245.01 | 186.63 | 100.16 | 44.32 | 81.89 | 29.23 |
| Total Non-Current Liabilities | 126K | 1.13M | 261K | 109K | 1.16M | 7.63M | 3.39M | 775K | 456K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 67K |
| Capital Lease Obligations | 0 | 0 | 261K | 109K | 984K | 760K | 544K | 307K | 67K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 126K | 0 | 0 | 0 | 179K | 6.87M | 2.84M | 468K | 389K |
| Total Liabilities | 2.22M | 2.84M | 3.61M | 3.69M | 4.47M | 12.32M | 6.56M | 3.33M | 3.49M |
| Total Debt | 0 | 0 | 447K | 339K | 1.18M | 984K | 760K | 545K | 328K |
| Net Debt | -15.6M | -5.48M | -832K | -14.1M | -7.57M | -16.75M | -3.04M | -4.55M | -757K |
| Debt / Equity | - | - | 0.22x | 0.02x | 0.05x | 0.08x | 0.24x | 0.08x | 0.13x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -5.82x | - | - | - | - | -1.86x | -5.06x | -1.96x | -1.05x |
| Total Equity | 16.24M▲ 0% | 5.94M▼ 63.4% | 1.99M▼ 66.5% | 16.32M▲ 720.0% | 25.95M▲ 59.0% | 12.36M▼ 52.4% | 3.21M▼ 74.0% | 6.53M▲ 103.4% | 2.62M▼ 59.8% |
| Equity Growth % | 824.19% | -63.44% | -66.48% | 720% | 59.01% | -52.38% | -74.01% | 103.36% | -59.82% |
| Book Value per Share | 999999.00 | 999999.00 | 45227.27 | 20893.73 | 13258.56 | 2485.82 | 57.21 | 4.92 | 0.38 |
| Total Shareholders' Equity | 16.24M | 5.94M | 1.99M | 16.32M | 25.95M | 12.36M | 3.21M | 6.53M | 2.62M |
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | 1K | 0 | 0 |
| Retained Earnings | -182.36M | -199.39M | -217.5M | -233.34M | -252.89M | -267.42M | -287.63M | -298.79M | -316.31M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 1.23M | 1.22M | 1.21M | -7K | -35K | 38K | -31K | -47K | 8K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NUWE Cash Flow Statement
Nuwellis, Inc. (NUWE) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -11.92M | -14.56M | -16.37M | -16.57M | -17.84M | -15.15M | -17.94M | -9.59M | -10.81M |
| Operating CF Margin % | -335.49% | -291.32% | -296.99% | -222.71% | -225.26% | -177.33% | -202.36% | -109.74% | -130.71% |
| Operating CF Growth % | 26.84% | -22.15% | -12.41% | -1.25% | -7.67% | 15.1% | -18.4% | 46.53% | -12.71% |
| Net Income | -13.38M | -17.03M | -18.11M | -15.84M | -19.55M | -14.53M | -20.21M | -11.16M | -17.52M |
| Depreciation & Amortization | 769K | 232K | 239K | 376K | 488K | 372K | 362K | 310K | 417K |
| Stock-Based Compensation | 499K | 2.09M | 1.51M | 1.35M | 1.31M | 862K | 670K | 478K | 127K |
| Deferred Taxes | 0 | 0 | -2.05M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 2.54M | 2.32M | 2.05M | -1.16M | 13K | -2.46M | 2.66M | 1.09M | 6.42M |
| Working Capital Changes | -2.35M | 153K | -4K | -1.3M | -104K | 598K | -1.42M | -305K | -253K |
| Change in Receivables | -263K | -241K | -13K | -106K | 155K | -656K | -545K | 224K | 234K |
| Change in Inventory | -911K | -70K | -343K | -1.42M | -143K | 140K | 697K | 279K | -192K |
| Change in Payables | -1.18M | 545K | 334K | 115K | 0 | 0 | -1.5M | 0 | 406K |
| Cash from Investing | -259K | -198K | -490K | -267K | -15.72M | 14.73M | 330K | -60K | -90K |
| Capital Expenditures | -259K | -198K | -490K | -298K | -219K | -122K | -149K | -60K | -90K |
| CapEx % of Revenue | 7.29% | 3.96% | 8.89% | 4% | 2.76% | 1.43% | 1.68% | 0.69% | 1.09% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 31K | 0 | 0 | -99K | 0 | 0 |
| Cash from Financing | 26.45M | 4.65M | 12.66M | 30.02M | 27.87M | 9.42M | 3.68M | 10.96M | 6.94M |
| Debt Issued (Net) | 0 | 0 | 0 | -20K | -26K | -26K | -28K | 0 | 0 |
| Equity Issued (Net) | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 1.99M | 0 | 0 | 4.12M | 1K | 0 | 120K | 2.53M | 0 |
| Net Change in Cash | 14.27M▲ 0% | -10.12M▼ 170.9% | -4.2M▲ 58.5% | 13.16M▲ 413.2% | -5.7M▼ 143.3% | 8.99M▲ 257.9% | -13.94M▼ 254.9% | 1.29M▲ 109.3% | -3.9M▼ 401.5% |
| Free Cash Flow | -12.18M▲ 0% | -14.76M▼ 21.2% | -16.86M▼ 14.2% | -16.87M▼ 0.1% | -18.06M▼ 7.1% | -15.27M▲ 15.5% | -18.18M▼ 19.1% | -9.65M▲ 46.9% | -10.9M▼ 12.9% |
| FCF Margin % | -342.78% | -295.28% | -305.88% | -226.72% | -228.03% | -178.75% | -205.16% | -110.42% | -131.8% |
| FCF Growth % | 25.78% | -21.18% | -14.22% | -0.08% | -7.07% | 15.45% | -19.08% | 46.93% | -12.94% |
| FCF per Share | -999999.00 | -999999.00 | -383113.64 | -21600.51 | -9229.43 | -3072.02 | -324.01 | -7.27 | -1.58 |
| FCF Conversion (FCF/Net Income) | 0.89x | 0.85x | 0.90x | 1.05x | 0.91x | 1.04x | 0.89x | 0.86x | 0.62x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 6K | 2K | 4K | 10K | 11K | 9K | 12K | 7K | 0 |
NUWE Key Ratios
Nuwellis, Inc. (NUWE) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -226.77% | -148.73% | -153.62% | -457.08% | -173% | -92.53% | -75.84% | -259.62% | -229.24% | -382.72% |
| Return on Invested Capital (ROIC) | -2706.57% | -2062.95% | -2325.2% | -1682.71% | -756.13% | -142.17% | -184.16% | -7732.46% | -766.25% | -433.04% |
| Gross Margin | 44.69% | 22.23% | 26.57% | 51.73% | 54.52% | 56.7% | 55.66% | 56.22% | 66.66% | 61.96% |
| Net Margin | -1225.14% | -376.64% | -340.78% | -328.69% | -212.82% | -246.86% | -170.02% | -227.99% | -127.75% | -211.81% |
| Debt / Equity | - | - | - | 0.22x | 0.02x | 0.05x | 0.08x | 0.24x | 0.08x | 0.13x |
| Interest Coverage | -31.08x | -5.82x | - | - | - | - | -1.86x | -5.06x | -1.96x | -1.05x |
| FCF Conversion | 1.03x | 0.89x | 0.85x | 0.90x | 1.05x | 0.91x | 1.04x | 0.89x | 0.86x | 0.62x |
| Revenue Growth | 2084.75% | 175.64% | 40.67% | 10.26% | 35.02% | 6.45% | 7.85% | 3.76% | -1.4% | -5.38% |
NUWE Frequently Asked Questions
Nuwellis, Inc. (NUWE) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Nuwellis, Inc. (NUWE) reported $8.3M in revenue for fiscal year 2025. This represents a 35195% increase from $0.0M in 2004.
Nuwellis, Inc. (NUWE) saw revenue decline by 5.4% over the past year.
Nuwellis, Inc. (NUWE) reported a net loss of $17.5M for fiscal year 2025.
Dividend & Returns
Nuwellis, Inc. (NUWE) has a return on equity (ROE) of -382.7%. Negative ROE indicates the company is unprofitable.
Nuwellis, Inc. (NUWE) had negative free cash flow of $10.9M in fiscal year 2025, likely due to heavy capital investments.
Explore More NUWE
Nuwellis, Inc. (NUWE) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates